Atebimetinib
Atebimetinib is an inhibitor for MEK tyrosine kinase and exhibits antineoplastic activity[1].
Product Specifications
CAS Number
2669009-92-9
UNSPSC
12352005
Target
MEK
Related Pathways
MAPK/ERK Pathway
Field of Research
Cancer
Purity
99.55
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C1OC2=C(C(CN(C)C)=C1CC3=C(F)C(NS(=O)(NC)=O)=CC=C3)C=CC(OC(N(C)C)=O)=C2
Molecular Formula
C23H27FN4O6S
Molecular Weight
506.55
References & Citations
[1]WHO-Volume38 Number4 2024
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC-16645-01 50 μL
Recombinant c-Jun (phospho S73) /JunD (phospho S100) Antibody
Sign In for Pricing
View Details RC-16645-02 100 µL
Recombinant c-Jun (phospho S73) /JunD (phospho S100) Antibody
Sign In for Pricing
View Details RC-16645-03 1 mL
Recombinant c-Jun (phospho S73) /JunD (phospho S100) Antibody
Sign In for Pricing
View Details 
VAng-Lsx4354-50gEcoli 50 µg (E. coli)
Recombinant Bordetella Parapertussis rpmD Protein (aa 1-61)
Sign In for Pricing
View Details 